BCBA/MDT (BCBA/MDT)

Buenos Aires Stock Exchange: BCBA/MDT · ARS

ARS 38,780

-880.46 (-2.2%)· Recorded snapshot

Market cap	176.9T
Revenue (ttm)	55.9T
Net income (ttm)	7.8T
EPS (ttm)	ARS 1,561
P/E (trailing)	24.8x
P/E (forward)	15.0x
Dividend	ARS 704 (1.82%)
Volume	230

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 55.9T
Net income (ttm): 7.8T
EPS (ttm): ARS 1,561
P/E (trailing): 24.8x
P/E (forward): 15.0x
Market cap: 176.9T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E15

P25 15P50 18.3P75 23.8

Trailing P/E24.8

P25 25.1P50 32.2P75 41.5

ROE10.6

P25 5P50 10.6P75 23.5

ROIC8.6

P25 7.2P50 13.5P75 19.8

Benchmarks · 1M

All BCBA/MDT indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

USD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Ireland
Country code	AR
Earnings date	2026-11-24
Employees	95,000
Employees change	0
Employees growth	0%
Enterprise value	ARS 207.3T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-07-31
First seen	2026-05-10
Fiscal year end	April
Founded	1949
Industry	Medical Devices
Is primary listing	No
ISIN number	ARDEUT111283
Last earnings date	2026-09-01
Last refreshed	2026-10-28
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 176.9T
Next earnings date	2026-11-24
Price	ARS 38,780.00
Price currency	ARS
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bcba/MDT
Website	https://www.medtronic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	30.46x
Average P/E ratio (3Y)	25.32x
Average P/E ratio (5Y)	26.8x
Earnings yield	4.03%
EV/Earnings	26.61x
EV/EBIT	17.87x
EV/EBITDA	12.58x
EV/FCF	22.7x
EV/Sales	3.59x
FCF / EV yield	4.41%
FCF yield	5.16%
Forward P/E	14.97x
Graham number	25260.24824
Graham upside	-34.86%
Lynch fair value	ARS 10,498.42
Lynch upside	-72.93%
P/(FCF - SBC) ratio	21.07x
P/(OCF - SBC) ratio	15.75x
P/B ratio	2.34x
P/E ratio	24.84x
P/FCF ratio	19.37x
P/OCF ratio	14.78x
P/S ratio	3.16x
Price/EBITDA ratio	11.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.1%
EBITDA margin	27.72%
Effective tax rate	20.19%
FCF margin	15.82%
Gross margin	65.27%
Operating margin	20.1%
Pretax margin	17.59%
Profit margin	13.93%
Profit per employee	ARS 82M
Profitable quarters	34
Profitable years	34
Revenue per employee	ARS 588.6M
ROA	5.12%
ROA (5Y)	4.49%
ROCE	9.26%
ROE	10.65%
ROE (5Y)	8.71%
ROIC	8.59%
ROIC (5Y)	7.72%
SBC / revenue	1.32%
Tax / revenue	3.55%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.12%
EPS growth (Q)	40.74%
EPS growth (QoQ)	17.56%
EPS growth 10Y	4.68%
EPS growth 3Y	14.42%
EPS growth 5Y	7.27%
EPS growth quarters	2
EPS growth years	2
FCF growth	15.63%
FCF growth (Q)	120.89%
FCF growth (QoQ)	-38.13%
FCF growth 3Y	11.33%
FCF growth 5Y	0.93%
Gross profit growth	9.58%
Gross profit growth (Q)	13.5%
Gross profit growth 3Y	5.58%
Gross profit growth 5Y	2.93%
Net income growth	12.25%
Net income growth (Q)	41.35%
Net income growth (QoQ)	18.17%
Net income growth 3Y	13.06%
Net income growth 5Y	6.15%
Net income growth quarters	2
Net income growth years	2
OCF growth	12.44%
OCF growth (Q)	64.8%
OCF growth (QoQ)	-30.31%
OCF growth 10Y	3.05%
OCF growth 3Y	11.28%
OCF growth 5Y	2.07%
Operating income growth	15.37%
Operating income growth (Q)	17.36%
Operating income growth 3Y	7.78%
Operating income growth 5Y	3.02%
Revenue growth	9.77%
Revenue growth (Q)	13.73%
Revenue growth (QoQ)	-0.52%
Revenue growth 10Y	2.71%
Revenue growth 3Y	5.96%
Revenue growth 5Y	3.51%
Revenue growth quarters	14
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -2.8T
Depreciation and amortization	ARS 4.4T
EBIT	ARS 11.2T
EBITDA	ARS 15.5T
EPS	ARS 1,561.19
Financing cash flow	ARS -5.5T
Free cash flow	ARS 9.1T
Free cash flow minus SBC	ARS 8.4T
Gross profit	ARS 36.5T
Income taxes	ARS 2T
Investing cash flow	ARS -5.7T
Net borrowing	ARS 232.3B
Net cash flow	ARS 622.6B
Net income	ARS 7.8T
Operating cash flow minus SBC	ARS 11.2T
Operating income	ARS 11.2T
Revenue	ARS 55.9T
Stock-based compensation	ARS 738.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.98
Book value per share	ARS 58,451.43
Debt / EBITDA	2.63
Debt / equity	0.55
Debt / FCF	4.59
Goodwill	ARS 66.4T
Interest coverage	10.41
Long-term assets	ARS 101.5T
Long-term liabilities	ARS 45.1T
Net cash (debt)	ARS -28.6T
Net cash / market cap	-16.14%
Net debt / EBITDA	1.84
Net debt / equity	0.38
Net debt / FCF	3.13
Piotroski F-Score	7
Property, plant and equipment	ARS 11.5T
Shareholders' equity	ARS 75.7T
Tangible book value	ARS -4.8T
Tangible book value per share	ARS -3,715.47
Total assets	ARS 139T
Total cash	ARS 13.1T
Total debt	ARS 41.9T
Total liabilities	ARS 63.2T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	ARS 37.5T
Current liabilities	ARS 18.2T
Current ratio	2.07
Inventory turnover	2.15
Net working capital	ARS 9.4T
Quick ratio	1.29
Working capital	ARS 18.8T
Working capital turnover	4,605.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0%
Dividend growth	27.56%
Dividend growth (10Y)	61.35%
Dividend growth (3Y)	83.5%
Dividend growth (5Y)	76.65%
Dividend growth years	16
Dividend payment date	2026-10-16
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 704.15
Dividend yield	1.82%
Ex-dividend date	2026-09-25
Last dividend	ARS 185.09
Payout ratio	69.78%
Shareholder yield	1.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 33,163.20
1D price change	-2.22%
1M price change	8.51%
1M total return	8.51%
1W price change	2.92%
1W total return	2.92%
1Y price change	5.9%
1Y return CAGR	8.15%
1Y total return	8.14%
20-day SMA	ARS 36,988.00
200-day SMA	ARS 33,957.00
3M price change	16.74%
3M total return	17.35%
3Y price change	152.64%
3Y return CAGR	38.85%
3Y total return	167.75%
50-day SMA	ARS 36,803.20
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 41,500.00
52-week high date	2025-11-27
52-week low	ARS 27,380.00
52-week low date	2026-05-29
5Y price change	524.58%
5Y return CAGR	46.55%
5Y total return	575.77%
6M price change	24.3%
6M total return	25.67%
All-time high	ARS 41,500.00
All-time high date	2025-11-27
All-time low	ARS 2,171.00
All-time low date	2019-12-16
Average true range (ATR)	ARS 855.91
Average volume	1.2K
Change from 52-week high	-6.55%
Change from 52-week low	41.64%
Change from all-time high	-6.55%
Change from all-time low	1,686.27%
Change from open	-1.47%
Day's gap	-0.76%
Dollar volume	ARS 8.9M
High price	ARS 39,360.00
Low price	ARS 38,780.00
Monthly RSI	62.35
Open price	ARS 39,360.00
Position in 52-week range	0%
Previous close	ARS 39,660.00
Price vs 150-day SMA	16.94%
Price vs 20-day SMA	4.84%
Price vs 200-day SMA	14.2%
Price vs 50-day SMA	5.37%
Relative volume	0.19
RSI	59.57
Sharpe ratio	0.45
Sharpe ratio (3Y)	1
Sharpe ratio (5Y)	1.25
Sortino ratio	0.88
Sortino ratio (3Y)	1.68
Sortino ratio (5Y)	2.07
Volume	230
Weekly RSI	63.06
YTD price change	5.55%
YTD total return	7.28%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2B
Shares change (QoQ)	-0.24%
Shares change (YoY)	0%
Shares held by insiders	0.04%
Shares held by institutions	91.04%
Short ratio	8.5 days

Deeper analysis on BCBA/MDT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/MDT report

Is a complete BCBA/MDT research report available?

No complete published report is available for bcba/MDT (BCBA/MDT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/MDT (BCBA/MDT)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/MDT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/MDT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/MDT

Frequently asked questions